Day: July 12, 2021

OMAHA, Neb., July 12, 2021 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) and Green Plains Partners LP (NASDAQ:GPP) will release second quarter 2021 financial results prior to the market opening on Monday, Aug. 2, 2021, and then host a joint conference call beginning at 11 a.m. Eastern time (10 a.m. Central time) to discuss second quarter performance and outlook. Domestic and international participants can access the conference call by dialing 877.711.2374 and 281.542.4862, respectively, and referencing conference ID 6498532. Participants are advised to call at least 10 minutes prior to the start time. Alternatively, the conference call and presentation can be accessed on either Green Plains’ website at https://investor.gpreinc.com/events-presentations or Green Plains Partners’ website at http://ir.greenplainspartners.com. About...

CAMBRIDGE, Mass., July 12, 2021 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced that it will report second quarter 2021 financial results after the market close on Monday, August 2, 2021. Management will host a conference call and webcast to discuss the Company’s financial results, recent developments and business outlook at 4:30 p.m. ET.What: EverQuote Second Quarter 2021 Financial Results Conference CallWhen: Monday, August 2, 2021Time: 4:30 p.m. ETLive Call: US/Canada Toll-Free: (877) 273-5005 International: (647) 689-5410Conference ID: 7777683Replay: US/Canada Toll-Free: (800) 585-8367International: (416) 621-4642Conference ID: 7777683(Available approximately two hours after the completion of the live call until 11:59 p.m. ET on August 9, 2021)Webcast: http://investors.everquote.com/About...

NEWTOWN, Pa., July 12, 2021 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences in July: The Ladenburg Thalmann Healthcare Conference, which is being held virtually from July 13th-14th.Management will present on Wednesday, July 14th at 11:30 a.m. Eastern Time.The Alliance Global Partners Virtual MedTech Summer Conference, which is being held virtually on July 29th.The conference format does not include company presentations. Management will participate in virtual 1×1 meetings on Thursday, July 29th.A webcast of the Ladenburg Thalmann Healthcare Conference presentation will be provided under the ‘Events’ section of...

SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About Adaptive BiotechnologiesAdaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing...

MORRISVILLE, N.C., July 12, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to its earnings call at 8:00 a.m. ET. Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00...

SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in a virtual fireside chat at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021 at 12:00 pm ET. To access the live webcast and subsequent archived recording of this and other company presentations, please visit the Investors section of Chinook’s website. The archived webcast will remain available for replay on Chinook’s website for 30 days. About Chinook Therapeutics, Inc.Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases. Chinook’s product candidates...

B. Riley Executive Brings Strong Financial Acumen to the Board BRIDGEWATER, N.J., July 12, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and digital solutions, is pleased to announce that Martin Bernstein has joined its Board of Directors, effective immediately. Bernstein was appointed to the Board in connection with the recent recapitalization of Synchronoss, and serves as a representative of B. Riley Financial, Inc. (NASDAQ: RILY) (B. Riley), the company’s largest shareholder. “On behalf of our entire Board, I am pleased to welcome Marty to our team,” said Stephen Waldis, Founder and Executive Chairman of the Synchronoss Board of Directors. “Marty’s extensive experience in capital allocation strategies, corporate governance and financing will serve our...

Company to highlight its latest product verbMAIL, an interactive video sales technology that integrates with Microsoft Outlook NEWPORT BEACH, Calif. and SALT LAKE CITY, July 12, 2021 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), a leader in interactive video-based sales enablement applications, including interactive livestream eCommerce, webinar, CRM and marketing applications for entrepreneurs and enterprises, today announced that CEO Rory J. Cutaia will present virtually at the Issuer Direct’s Access to Giving Virtual Investor Conference to be held July 13-15, 2021. Mr. Cutaia will provide a Company overview which includes its suite of products: verbCRM, verbLIVE, verbTEAMS, verbLEARN, as well as the recently launched, verbMAIL, its latest interactive...

QUEBEC CITY, July 12, 2021 (GLOBE NEWSWIRE) — ORLETTO CAPITAL II INC. (TSX-V “OLT.P”) (the “Corporation”) is pleased to announce that all matters submitted to its shareholders for approval as set out in detail in the Corporation’s management information circular dated May 25, 2021 (the “Circular”) were approved at the annual general and special meeting of the shareholders of the Corporation held on June 22, 2021 (the “Meeting”). At the Meeting, the incumbent members of the board of directors, being Benoit Chotard, Octavio Soares, Claude Pouliot and Cynthia Mailloux, were elected as directors, Mallette LLP was re-appointed as the auditor of the Corporation, and the Corporation’s proposed stock option plan was approved and confirmed, conditional to the completion of a qualifying transaction. Moreover, the shareholders of the Corporation...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., July 12, 2021 (GLOBE NEWSWIRE) — Avisa Diagnostics Inc. (CSE:AVBT) (“Avisa” or the “Company”), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement (the “Offering”) of 1,390,000 common shares (“Common Shares”) of the Company to raise approximately CAN$375,000 at a price of CAN$0.27 per Common Share. Avisa intends to use the net proceeds from the Offering for operations and expansion of its business and for general working capital purposes. The Offering is expected to close on or about July 15, 2021, subject to satisfaction...